EUVIMEDEUVIMED entdecken
Crossref

Serological status for TORCH in women of childbearing age: a decade-long surveillance (2012–2022) in Italy

Emilia Palazzotto, Floriana Bonura, Cinzia Calà, Giuseppina Capra, Daniela Pistoia, Donatella Mangione, Chiara Mascarella, Giuseppe Minì, Marco Enea, Giovanni M Giammanco, Donatella Ferraro, Simona De Grazia

Journal of Medical Microbiology · 2023

DOI: 10.1099/jmm.0.001733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Microbiology, 2023. Verfasst von Emilia Palazzotto und 11 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology Section, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties 'G. D'Alessandro', University …. Hauptthemen laut MEDLINE: Toxoplasmosis, Cytomegalovirus Infections, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Ministero dell’Istruzione, dell’Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Serological screening and seroprevalence data for TORCH infections represent a key instrument to estimate immunity and vaccination levels and exposure rates to prevent and treat TORCH congenital infections. Hypothesis. Serology allows us to identify women susceptible to primary infection.

Aim

Assess the prevalence of women at risk of primary infections by TORCH pathogens in Palermo, Sicily, Italy, in the decade 2012–2022. Methodology. A retrospective study was performed to evaluate the serological status (IgG and/or IgM) of 2359 women of childbearing age (WCBA), ranging from 16 to 46 years, attending the AOUP ‘P. Giaccone’ University Hospital of Palermo.

Results

The results showed an overall prevalence of anti-TORCH IgG of 90.5 % for herpesvirus (HSV), 81.2 % for rubella virus (RV), 72.1 % for cytomegalovirus (CMV), 20.9 % for Toxoplasma gondii (TOX) and 4.8 % for Treponema pallidum (TP). IgM positivity was 16.9 % for HSV2, 10.3 % for TOX, 4 % for CMV and, 2 % for RV. A recent/active infection by TP was confirmed in 28.3 % of the seropositive women. Our results indicate that only a small percentage of WCBA were subjected to a comprehensive TORCH serological screening, while most WCBA were only tested for a single pathogen. In addition, no significant differences were found in terms of the overall TORCH IgG seroprevalence among different age groups ( P >0.05).

Conclusion

Identifying WCBA at risk of exposure during pregnancy allows us to prevent and reduce possible congenital infections, providing detailed guidelines and instructions. The results of this study showed that in Italy the risk of acquiring a primary infection by a TORCH agent is still high, therefore effective prevention strategies, including serological screening, should be implemented.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ToxoplasmosisCytomegalovirus InfectionsPregnancy Complications, InfectiousPregnancyHumansFemaleRetrospective StudiesSeroepidemiologic StudiesCytomegalovirusItalyImmunoglobulin GImmunoglobulin M

Stichwörter der Autor:innen

ItalyTORCHchildbearing ageseroprevalencewomen

Substanzen

Immunoglobulin GImmunoglobulin M

Autor:innen und Institutionen

  • Microbiology Section, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties 'G. D'Alessandro', University of Palermo, Palermo, Italy.
  • Unit of Microbiology and Virology, University Hospital 'P. Giaccone', Palermo, Italy.
  • Gynecology Section, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties 'G. D'Alessandro', University of Palermo, Palermo, Italy.

Förderung

  • Ministero dell’Istruzione, dell’Università e della Ricerca

Zitieren

APA

Palazzotto, E., Bonura, F., Calà, C., Capra, G., Pistoia, D., Mangione, D., Mascarella, C., Minì, G., Enea, M., Giammanco, G. M., Ferraro, D., & De Grazia, S. (2023). Serological status for TORCH in women of childbearing age: a decade-long surveillance (2012–2022) in Italy. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.001733

Vancouver

Palazzotto E, Bonura F, Calà C, Capra G, Pistoia D, Mangione D, et al. Serological status for TORCH in women of childbearing age: a decade-long surveillance (2012–2022) in Italy. Journal of Medical Microbiology. 2023. doi:10.1099/jmm.0.001733

BibTeX
@article{Palazzotto2023,
  author = {Palazzotto, Emilia and Bonura, Floriana and Calà, Cinzia and Capra, Giuseppina and Pistoia, Daniela and Mangione, Donatella and Mascarella, Chiara and Minì, Giuseppe and Enea, Marco and Giammanco, Giovanni M and Ferraro, Donatella and De Grazia, Simona},
  title = {Serological status for TORCH in women of childbearing age: a decade-long surveillance (2012–2022) in Italy},
  journal = {Journal of Medical Microbiology},
  year = {2023},
  doi = {10.1099/jmm.0.001733}
}
Kostenlos starten →